|
1
|
Boehm A, Wichmann G, Mozet C and Dietz A:
Current therapy options in recurrent head and neck cancer. HNO.
58:762–769. 2010.(In German).
|
|
2
|
Mannelli G and Gallo O: Cancer stem cells
hypothesis and stem cells in head and neck cancers. Cancer Treat
Rev. 38:515–539. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oker N, Kaufmann AM and Albers AE: Biology
and relevance of stem cells in squamous head and neck cancer:
latest insights and review of literature. Laryngorhinootologie.
91:326–332. 2012.(In German).
|
|
5
|
Clay MR, Tabor M, Owen JH, et al:
Single-marker identification of head and neck squamous cell
carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck.
32:1195–1201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen YS, Wu MJ, Huang CY, et al: CD133/Src
axis mediates tumor initiating property and epithelial-mesenchymal
transition of head and neck cancer. PLoS One. 6:e280532011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Franzmann EJ, Reategui EP, Pedroso F, et
al: Soluble CD44 is a potential marker for the early detection of
head and neck cancer. Cancer Epidemiol Biomarkers Prev.
16:1348–1355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ponta H, Wainwright D and Herrlich P: The
CD44 protein family. Int J Biochem Cell Biol. 30:299–305. 1998.
View Article : Google Scholar
|
|
9
|
Screaton GR, Bell MV, Bell JI and Jackson
DG: The identification of a new alternative exon with highly
restricted tissue expression in transcripts encoding the mouse
Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons
between mouse, human, and rat. J Biol Chem. 268:12235–12238.
1993.
|
|
10
|
Screaton GR, Bell MV, Jackson DG, Cornelis
FB, Gerth U and Bell JI: Genomic structure of DNA encoding the
lymphocyte homing receptor CD44 reveals at least 12 alternatively
spliced exons. Proc Natl Acad Sci USA. 89:12160–12164. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Günthert U, Hofmann M, Rudy W, et al: A
new variant of glycoprotein CD44 confers metastatic potential to
rat carcinoma cells. Cell. 65:13–24. 1991.PubMed/NCBI
|
|
12
|
Hofmann M, Rudy W, Zoller M, et al: CD44
splice variants confer metastatic behavior in rats: homologous
sequences are expressed in human tumor cell lines. Cancer Res.
51:5292–5297. 1991.PubMed/NCBI
|
|
13
|
Zhang H, Xi H, Cai A, et al: Not all side
population cells contain cancer stem-like cells in human gastric
cancer cell lines. Dig Dis Sci. Aug 10–2012.(Epub ahead of
print).
|
|
14
|
Pang RW and Poon RT: Cancer stem cell as a
potential therapeutic target in hepatocellular carcinoma. Curr
Cancer Drug Targets. Aug 2–2012.(Epub ahead of print).
|
|
15
|
Park SY, Lee HE, Li H, Shipitsin M, Gelman
R and Polyak K: Heterogeneity for stem cell-related markers
according to tumor subtype and histologic stage in breast cancer.
Clin Cancer Res. 16:876–887. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeimet AG, Reimer D, Sopper S, et al:
Ovarian cancer stem cells. Neoplasma. 59:747–755. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dar A, Goichberg P, Shinder V, et al:
Chemokine receptor CXCR4-dependent internalization and resecretion
of functional chemokine SDF-1 by bone marrow endothelial and
stromal cells. Nat Immunol. 6:1038–1046. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Faber A, Roderburg C, Wein F, et al: The
many facets of SDF-1alpha, CXCR4 agonists and antagonists on
hematopoietic progenitor cells. J Biomed Biotechnol.
2007:260652007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De La Luz Sierra M, Yang F, Narazaki M, et
al: Differential processing of stromal-derived factor-1alpha and
stromal-derived factor-1beta explains functional diversity. Blood.
103:2452–2459. 2004.PubMed/NCBI
|
|
20
|
Shirozu M, Nakano T, Inazawa J, et al:
Structure and chromosomal localization of the human stromal
cell-derived factor 1 (SDF1) gene. Genomics. 28:495–500. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim CH and Broxmeyer HE: In vitro behavior
of hematopoietic progenitor cells under the influence of
chemoattractants: stromal cell-derived factor-1, steel factor, and
the bone marrow environment. Blood. 91:100–110. 1998.PubMed/NCBI
|
|
22
|
Mohle R, Bautz F, Rafii S, Moore MA,
Brugger W and Kanz L: The chemokine receptor CXCR-4 is expressed on
CD34+ hematopoietic progenitors and leukemic cells and
mediates transendothelial migration induced by stromal cell-derived
factor-1. Blood. 91:4523–4530. 1998.PubMed/NCBI
|
|
23
|
Petit I, Goichberg P, Spiegel A, et al:
Atypical PKC-zeta regulates SDF-1-mediated migration and
development of human CD34+ progenitor cells. J Clin
Invest. 115:168–176. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chute JP: Stem cell homing. Curr Opin
Hematol. 13:399–406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fruehauf S, Srbic K, Seggewiss R, Topaly J
and Ho AD: Functional characterization of podia formation in normal
and malignant hematopoietic cells. J Leukoc Biol. 71:425–432.
2002.PubMed/NCBI
|
|
26
|
Lataillade JJ, Clay D, Dupuy C, et al:
Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in
synergy with cytokines: possible role in progenitor survival.
Blood. 95:756–768. 2000.
|
|
27
|
Broxmeyer HE, Kohli L, Kim CH, et al:
Stromal cell-derived factor-1/CXCL12 directly enhances
survival/antiapoptosis of myeloid progenitor cells through CXCR4
and G(alpha)i proteins and enhances engraftment of competitive,
repopulating stem cells. J Leukoc Biol. 73:630–638. 2003.
View Article : Google Scholar
|
|
28
|
Kijowski J, Baj-Krzyworzeka M, Majka M, et
al: The SDF-1-CXCR4 axis stimulates VEGF secretion and activates
integrins but does not affect proliferation and survival in
lymphohematopoietic cells. Stem Cells. 19:453–466. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hattori K, Heissig B, Tashiro K, et al:
Plasma elevation of stromal cell-derived factor-1 induces
mobilization of mature and immature hematopoietic progenitor and
stem cells. Blood. 97:3354–3360. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kremer KN, Clift IC, Miamen AG, et al:
Stromal cell-derived factor-1 signaling via the CXCR4-TCR
heterodimer requires phospholipase C-β3 and phospholipase C-γ1 for
distinct cellular responses. J Immunol. 187:1440–1447.
2011.PubMed/NCBI
|
|
31
|
La Porta CA: Thoughts about cancer stem
cells in solid tumors. World J Stem Cells. 4:17–20. 2012.PubMed/NCBI
|
|
32
|
Grosse-Gehling P, Fargeas CA, Dittfeld C,
et al: CD133 as a biomarker for putative cancer stem cells in solid
tumours: limitations, problems and challenges. J Pathol. Aug
16–2012.(Epub ahead of print).
|
|
33
|
Schubert M, Herbert N, Taubert I, et al:
Differential survival of AML subpopulations in NOD/SCID mice. Exp
Hematol. 39:250–263. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jamal M, Rath BH, Tsang PS, Camphausen K
and Tofilon PJ: The brain microenvironment preferentially enhances
the radioresistance of CD133(+) glioblastoma stem-like cells.
Neoplasia. 14:150–158. 2012.PubMed/NCBI
|
|
35
|
Wollenberg B: Implication of stem cells in
the biology and therapy of head and neck cancer.
Laryngorhinootologie. 90(Suppl 1): S110–S119. 2011.(In German).
|
|
36
|
Warrier S, Pavanram P, Raina D and Arvind
M: Study of chemoresistant CD133+cancer stem cells from
human glioblastoma cell line U138MG using multiple assays. Cell
Biol Int. Jul 6–2012.(Epub ahead of print).
|
|
37
|
Jaggupilli A and Elkord E: Significance of
CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
Clin Dev Immunol. 2012:7080362012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pries R, Wittkopf N, Hasselbacher K and
Wollenberg B: Constitutive expression of the potential stem cell
marker CD44 in permanent HNSCC cell lines. HNO. 56:461–466.
2008.(In German).
|
|
39
|
Badve S and Nakshatri H: Breast-cancer
stem cells - beyond semantics. Lancet Oncol. 13:e43–e48. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang F, Qiu Q, Khanna A, et al: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Charafe-Jauffret E, Ginestier C, Iovino F,
et al: Aldehyde dehydrogenase 1-positive cancer stem cells mediate
metastasis and poor clinical outcome in inflammatory breast cancer.
Clin Cancer Res. 16:45–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Silva IA, Bai S, McLean K, et al: Aldehyde
dehydrogenase in combination with CD133 defines angiogenic ovarian
cancer stem cells that portend poor patient survival. Cancer Res.
71:3991–4001. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sterz CM, Kulle C, Dakic B, et al: A
basal-cell-like compartment in head and neck squamous cell
carcinomas represents the invasive front of the tumor and is
expressing MMP-9. Oral Oncol. 46:116–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nakajima M, Gohji K, Fabra A, Fidler IA
and Tsuruo T: Regulation of tumor metastasis and extracellular
matrix degradative enzyme production by microenvironments. Gan To
Kagaku Ryoho. 20:380–386. 1993.(In Japanese).
|
|
45
|
Schultz JD, Rotunno S, Erben P, et al:
Down-regulation of MMP-2 expression due to inhibition of receptor
tyrosine kinases by imatinib and carboplatin in HNSCC. Oncol Rep.
25:1145–1151. 2011.PubMed/NCBI
|
|
46
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Metzen E, Jin F, Brockmeier U and
Otterbach F: New insight into the SDF-1/CXCR4 axis in a breast
carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell
CXCR4 are required for tumor cell intravasation. Mol Cancer Res.
10:1021–1031. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Purizaca J, Meza I and Pelayo R: Early
lymphoid development and microenvironmental cues in B-cell acute
lymphoblastic leukemia. Arch Med Res. 43:89–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Juarez J, Dela Pena A, Baraz R, et al:
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia
cells into the peripheral blood and inhibit engraftment. Leukemia.
21:1249–1257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Clatot F, Picquenot JM, Choussy O, et al:
Intratumoural level of SDF-1 correlates with survival in head and
neck squamous cell carcinoma. Oral Oncol. 47:1062–1068. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Geutskens SB, Andrews WD, van Stalborch
AM, et al: Control of human hematopoietic stem/progenitor cell
migration by the extracellular matrix protein Slit3. Lab Invest.
92:1129–1139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ghosh MC, Makena PS, Gorantla V, Sinclair
SE and Waters CM: CXCR4 regulates migration of lung alveolar
epithelial cells through activation of Rac1 and matrix
metalloproteinase-2. Am J Physiol Lung Cell Mol Physiol.
302:L846–L856. 2012. View Article : Google Scholar : PubMed/NCBI
|
